ABSTRACT
We report an outbreak of conjunctivitis due to Pseudomonas aeruginosa involving seven infants admitted in the Neonatal Intensive Care Unit (NICU) of the Uberlândial Federal University Hospital between March and September 2001. Three infants developed systemic complications (01 sepsis and 02 pneumonias). Ten isolates were obtained from conjunctival cultures and all were resistant to ceftazidime and aminoglycosides. Fast identification of the organism and treatment with imipenem were important in containing the outbreak of P. aeruginosa.
Subject(s)
Conjunctivitis/epidemiology , Cross Infection/epidemiology , Disease Outbreaks , Pseudomonas Infections/epidemiology , Anti-Bacterial Agents/therapeutic use , Brazil/epidemiology , Ciprofloxacin/therapeutic use , Conjunctivitis/drug therapy , Conjunctivitis/microbiology , Cross Infection/microbiology , Drug Resistance, Multiple, Bacterial , Humans , Imipenem/therapeutic use , Infant, Newborn , Intensive Care Units, Neonatal , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purificationABSTRACT
We report an outbreak of conjunctivitis due to Pseudomonas aeruginosa involving seven infants admitted in the Neonatal Intensive Care Unit (NICU) of the Uberlândial Federal University Hospital between March and September 2001. Three infants developed systemic complications (01 sepsis and 02 pneumonias). Ten isolates were obtained from conjunctival cultures and all were resistant to ceftazidime and aminoglycosides. Fast identification of the organism and treatment with imipenem were important in containing the outbreak of P. aeruginosa
